Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types ; volume:15 ; number:1 ; day:23 ; month:12 ; year:2024 ; pages:1-23 ; date:12.2024
Discover oncology ; 15, Heft 1 (23.12.2024), 1-23, 12.2024
- Creator
-
Xu, Peiyi
Zhang, Qiuyan
Zhai, Jing
Chen, Pu
Deng, Xueting
Miao, Lin
Zhang, Xiuhua
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01697-4
- URN
-
urn:nbn:de:101:1-2503032106114.453415101913
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Xu, Peiyi
- Zhang, Qiuyan
- Zhai, Jing
- Chen, Pu
- Deng, Xueting
- Miao, Lin
- Zhang, Xiuhua
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
NEK2 is a potential pan-cancer biomarker and immunotherapy target
A pan-cancer analysis of synonymous mutations
Pan-cancer landscape of homologous recombination deficiency
Systematic characterization of pan‐cancer mutation clusters
A pan-cancer analysis of synonymous mutations
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
NEK2 is a potential pan-cancer biomarker and immunotherapy target
A pan-cancer analysis of synonymous mutations
Pan-cancer landscape of homologous recombination deficiency
Systematic characterization of pan‐cancer mutation clusters
A pan-cancer analysis of synonymous mutations
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
Pan-cancer patterns of DNA methylation
Pan-cancer analysis of whole genomes
Pan-cancer analysis of whole genomes
NEK2 is a potential pan-cancer biomarker and immunotherapy target
A pan-cancer analysis of synonymous mutations
Pan-cancer landscape of homologous recombination deficiency
Systematic characterization of pan‐cancer mutation clusters